Sutro Biopharma (STRO) Current Leases (2021 - 2026)
Sutro Biopharma (STRO) posted Current Leases of $7.8 million for Q4 2025, down 2.22% sequentially from $8.0 million in Q3 2025, and up 4.05% YoY from $7.5 million in Q4 2024.
Sutro Biopharma (STRO) Current Leases (2021 - 2026) Analysis & Trends
Sutro Biopharma has reported Current Leases for 5 years, with the latest figure at $7.8 million in Q4 2025.
- Quarterly Current Leases rose 4.05% year-over-year to $7.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.8 million (up 4.05% YoY) and the FY2025 annual result came in at $7.8 million, up 4.05% from the prior year.
- Current Leases retreated to $7.8 million in Q4 2025 per STRO's latest filing, from $8.0 million in the prior quarter.
- Over five years, Current Leases peaked at $8.1 million in Q2 2025 and troughed at $1.0 million in Q4 2021.
- A 5-year average of $5.3 million and a median of $6.3 million in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2025: Current Leases jumped 429.82% in 2023, then gained 4.05% in 2025.
- Over 5 years, Current Leases stood at $1.0 million in 2021, then jumped by 342.14% to $4.6 million in 2022, then jumped by 40.02% to $6.4 million in 2023, then increased by 16.51% to $7.5 million in 2024, then grew by 4.05% to $7.8 million in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $7.8 million, $8.0 million, and $8.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - | 6.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.66 Mn |
| Dec 31, 2025 | 7.78 Mn |
| Sep 30, 2025 | 7.96 Mn |
| Jun 30, 2025 | 8.06 Mn |
| Mar 31, 2025 | 7.77 Mn |
| Dec 31, 2024 | 7.48 Mn |
| Sep 30, 2024 | 7.20 Mn |
| Jun 30, 2024 | 6.93 Mn |
| Mar 31, 2024 | 6.67 Mn |
| Dec 31, 2023 | 6.42 Mn |
| Sep 30, 2023 | 6.17 Mn |
| Jun 30, 2023 | 5.93 Mn |
| Mar 31, 2023 | 5.25 Mn |
| Dec 31, 2022 | 4.59 Mn |
| Sep 30, 2022 | 2.63 Mn |
| Jun 30, 2022 | 1.12 Mn |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 1.45 Mn |